A
THC icon

Astrantus’s Tenet Healthcare THC Stock Holding History

Astrantus’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$223K Buy
+2,600
New +$214K 0.38% 158

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Astrantus's THC Position: Q1 2022 in Review

Astrantus opened a new position in Tenet Healthcare (THC) in Q1 2022: 2,600 shares worth $223K. The stake represents 0.38% of the portfolio and ranks #158 among its holdings.

404 funds tracked by Wall St. Rank hold THC as of Q1 2022.

  • Astrantus held 2,600 shares of Tenet Healthcare worth $223K as of Q1 2022.
  • Tenet Healthcare was a new Astrantus position in Q1 2022.
  • Tenet Healthcare made up 0.38% of Astrantus's portfolio in Q1 2022, its #158 holding.
  • 404 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.